Center for Program Integrity

Dara Corrigan is the Deputy Administrator and Director of the Center for Program Integrity, charged with leading CMS's efforts to prevent fraud and abuse. She recently served as a vice president at Fresenius Kabi, a global health care company. Ms. Corrigan has more than 20 years of government service in health care-related positions, including a tenure as Associate Commissioner for Global Regulatory Policy at the Food and Drug Administration, where she was FDA’s lead negotiator for the Mutual Recognition Agreement with the European Union (EU), allowing the U.S. and EU to eliminate duplicative drug manufacturing inspections. Ms. Corrigan's career also includes drafting regulations under the Affordable Care Act that overhauled the private insurance market, serving as the Acting Inspector General at the Department of Health and Human Services, and practicing law at the Department of Justice for eight years. Combined with her private sector experience, she brings a deep knowledge of health care systems, drug development, safety and quality issues, and private and public payors – a combination that powerfully equips her to coordinate the prevention of fraud and abuse in the Medicare, Medicaid, and CHIP programs. She received her Juris Doctor from the University of Virginia in 1990 and her undergraduate degree from Baylor University.

Amy Turner is Deputy Center Director for CMS’s Center for Program Integrity. She oversees the Provider Enrollment & Oversight Program, the Fraud Investigations Program, and the Provider Compliance Program. Amy joined CMS after spending over 25 years at the US Department of Labor, including serving as the Deputy Assistant Secretary for Regional Operations at the Employee Benefits Security Administration (EBSA). Earlier in her career, Amy was the Director of Health Plan Standards and Compliance Assistance at EBSA, where she managed regulations, interpretive guidance, and implementation activities for private-sector group health plans. Her responsibilities included coordination with the Departments of HHS and the Treasury, as well as other Federal and State agencies, to implement various provisions of Federal health care law, including the Affordable Care Act. Amy earned a Bachelor of Science from Cornell University and a Juris Doctor from the George Washington University Law School. 

Jeneen Iwugo is the Acting Deputy Director of the Center for Program Integrity, with executive responsibility for operational leadership and execution of the Center’s $1 billion annual budget and resource management of over 500 FTEs.  Jeneen has over 20 years of government leadership, operations management, and policy development expertise.

Throughout her federal career, Jeneen has led healthcare quality innovation, beneficiary complaint and appeal reviews, redesign of large-scale contractor oversight and fiscal accountability procedures, and organizational change management efforts. Jeneen designed fundamental changes to the Quality Improvement Organization (QIO) statute and led a substantial revision to the QIO program eligibility regulations which dramatically expanded program requirements and broadened the pool of organizations with which the agency can establish contracts. Jeneen brings a proven ability to align programs with evolving agency priorities and objectives. With a reputation for candor and transparency, Jeneen has a track record of successfully meeting and exceeding agency operational goals with proven results.

• Serves as CMS' focal point for all national and State-wide Medicare and Medicaid programs and CHIP integrity fraud and abuse issues.
• Promotes the integrity of the Medicare and Medicaid programs and CHIP through provider/contractor audits and policy reviews, identification and monitoring of program vulnerabilities, and providing support and assistance to States. Recommends modifications to programs and operations as necessary and works with CMS Centers, Offices, and the Chief Operating Officer (COO) to affect changes as appropriate. Collaborates with the Office of Legislation on the development and advancement of new legislative initiatives and improvements to deter, reduce, and eliminate fraud, waste and abuse.
• Oversees all CMS interactions and collaboration with key stakeholders relating to program integrity (i.e., U.S. Department of Justice, DHHS Office of Inspector General, State law enforcement agencies, other Federal entities, CMS components) for the purposes of detecting, deterring, monitoring and combating fraud and abuse, as well as taking action against those that commit or participate in fraudulent or other unlawful activities.
• In collaboration with other CMS Centers, Offices, and the COO, develops and implements a comprehensive strategic plan, objectives and measures to carry out CMS' Medicare, Medicaid and CHIP program integrity mission and goals, and ensure program vulnerabilities are identified and resolved.